Switch to: References

Add citations

You must login to add citations.
  1. Licensing Surrogate Decision-Makers.Philip M. Rosoff - 2017 - HEC Forum 29 (2):145-169.
    As medical technology continues to improve, more people will live longer lives with multiple chronic illnesses with increasing cumulative debilitation, including cognitive dysfunction. Combined with the aging of society in most developed countries, an ever-growing number of patients will require surrogate decision-makers. While advance care planning by patients still capable of expressing their preferences about medical interventions and end-of-life care can improve the quality and accuracy of surrogate decisions, this is often not the case, not infrequently leading to demands for (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Limiting court involvement in end-of-life treatment decisions for children in England & Wales: Advantages and limitations of a specialist committee deciding on futility.Veronica M. E. Neefjes - forthcoming - Clinical Ethics.
    Given the costs of litigation high-profile court cases about withdrawing life-sustaining medical treatment for seriously ill children in England & Wales tend to be followed by discussion about how to avoid similar cases in future. Whilst two proposals, mediation and replacing the best interests standard with a harm threshold, have received broad attention, a proposal to replace the court by a specialist review committee has not been further investigated. This article analyses the effects of a putative replacement of the courts (...)
    Download  
     
    Export citation  
     
    Bookmark